[RGLS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 78.06%
YoY- 71.90%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 0 0 5,000 5,000 0 6 18 -
PBT -6,033 -6,013 -1,315 -1,523 -6,947 -5,945 -4,893 14.99%
Tax 1 -335 7 1 10 -8 -131 -
NP -6,034 -6,013 -1,322 -1,524 -6,947 -5,937 -4,893 15.01%
Tax Rate - - - - - - - -
Total Cost 6,034 6,013 6,322 6,524 6,947 5,943 4,911 14.73%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.00 0.00 -26.44 -30.48 0.00 -98,950.00 -27,183.33 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.78 -0.84 -0.28 -0.40 -2.33 -2.47 -2.34 -51.95%
EPS Diluted -0.78 -0.84 -0.28 -0.40 -2.33 -2.47 -2.34 -51.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.